Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITAL Rhythm Study
NCT02178410Phase 3Active, not recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Oct 2012
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3 fatty acid, vitamin d in Atrial fibrillation (AFib), sudden cardiac death (SCD), sponsored by Brigham and Women's Hospital. Started Oct 2012; status: active, not recruiting.
02
Drugs
omega-3 fatty acidvitamin d
03
Conditions
Atrial fibrillation (AFib)sudden cardiac death (SCD)
Beyond the preview
Go deeper on NCT02178410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02178410.